Anti-cancer
Paclitaxel
CAS No.
33069-62-4
A microtubule-stabilizing taxane derived from Taxus species, used in injectable oncology formulations for ovarian, breast, and lung cancers.
Paclitaxel is a plant-derived taxane oncology API manufactured by NovaAcura Biotech under stringent GMP quality systems appropriate to cytotoxic API handling. The company supplies full batch documentation and regulatory support to global oncology formulation partners.
Applications & Uses
A microtubule-stabilizing taxane derived from Taxus species, used in injectable oncology formulations for ovarian, breast, and lung cancers.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch